Casma Therapeutics

Casma Therapeutics, founded in Cambridge, United States, is dedicated to developing innovative medicines by harnessing the natural process of autophagy. Their mission is to leverage this cellular degradation mechanism to create treatments for a broad range of diseases. By reprogramming autophagy, Casma aims to target and eliminate damaged cellular components, thereby maintaining cellular health and preventing disease. Their platform focuses on the science of autophagy to develop a robust pipeline of therapeutic candidates.

Notable individuals associated with Casma Therapeutics include leading scientists and industry experts who contribute to their pioneering research. The company has attracted significant investment from prominent biotech investors, enabling them to advance their drug development programs. Key achievements include the successful development of a proprietary platform for autophagy-based therapies and progress in preclinical studies. Casma's innovative approach has the potential to transform treatment paradigms for various diseases, making a substantial impact on healthcare.